Wall Street brokerages expect Vitamin Shoppe, Inc (NYSE:VSI) to report $0.39 earnings per share (EPS) for the current quarter, according to Zacks. Three analysts have issued estimates for Vitamin Shoppe’s earnings, with the lowest EPS estimate coming in at $0.34 and the highest estimate coming in at $0.48. Vitamin Shoppe reported earnings of $0.55 per share during the same quarter last year, which indicates a negative year over year growth rate of 29.1%. The firm is expected to report its next earnings results on Wednesday, August 2nd.

On average, analysts expect that Vitamin Shoppe will report full year earnings of $1.56 per share for the current fiscal year, with EPS estimates ranging from $1.50 to $1.63. For the next year, analysts expect that the firm will post earnings of $1.62 per share, with EPS estimates ranging from $1.51 to $1.70. Zacks’ EPS calculations are an average based on a survey of research analysts that that provide coverage for Vitamin Shoppe.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, May 10th. The specialty retailer reported $0.37 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.21. The company had revenue of $316.90 million during the quarter, compared to the consensus estimate of $325.71 million. Vitamin Shoppe had a net margin of 1.43% and a return on equity of 9.35%. The firm’s quarterly revenue was down 5.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.67 EPS.

Several equities research analysts have recently weighed in on VSI shares. Zacks Investment Research cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Wednesday, May 3rd. Barclays PLC reiterated an “equal weight” rating and set a $13.00 price objective (down from $24.00) on shares of Vitamin Shoppe in a research report on Sunday, May 14th. ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Gabelli cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Finally, Morgan Stanley upgraded shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price objective for the company in a research report on Thursday, May 11th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $24.00.

COPYRIGHT VIOLATION NOTICE: This story was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/07/27/vitamin-shoppe-inc-vsi-expected-to-post-earnings-of-0-39-per-share.html.

Shares of Vitamin Shoppe (NYSE VSI) traded up 1.39% on Thursday, reaching $10.95. 99,056 shares of the company’s stock were exchanged. The company has a market cap of $253.63 million, a price-to-earnings ratio of 14.09 and a beta of 0.69. Vitamin Shoppe has a 12 month low of $9.80 and a 12 month high of $31.50. The firm’s 50-day moving average price is $11.12 and its 200 day moving average price is $16.98.

Hedge funds and other institutional investors have recently modified their holdings of the company. Municipal Employees Retirement System of Michigan raised its position in shares of Vitamin Shoppe by 18.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after buying an additional 1,440 shares in the last quarter. Mason Street Advisors LLC raised its position in shares of Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares in the last quarter. Capstone Asset Management Co. raised its position in shares of Vitamin Shoppe by 3.5% in the second quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock valued at $164,000 after buying an additional 470 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Vitamin Shoppe during the first quarter valued at about $208,000. Finally, Arizona State Retirement System raised its position in shares of Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock valued at $249,000 after buying an additional 100 shares in the last quarter.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.